RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $162 | -99.8% | 5,581 | -78.4% | 0.00% | – |
Q2 2022 | $107,000 | +143.2% | 25,890 | +564.0% | 0.00% | – |
Q1 2022 | $44,000 | +33.3% | 3,899 | +16.5% | 0.00% | – |
Q4 2021 | $33,000 | -63.7% | 3,348 | -24.0% | 0.00% | – |
Q3 2021 | $91,000 | -9.9% | 4,404 | -15.4% | 0.00% | – |
Q2 2021 | $101,000 | +1.0% | 5,204 | +10.3% | 0.00% | – |
Q1 2021 | $100,000 | -67.0% | 4,716 | -53.8% | 0.00% | – |
Q4 2020 | $303,000 | +194.2% | 10,200 | +113.2% | 0.00% | – |
Q3 2020 | $103,000 | +472.2% | 4,785 | +295.8% | 0.00% | – |
Q1 2020 | $18,000 | – | 1,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |